Exelixis (EXEL) director nets 30,250-share sale and option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Exelixis, Inc. director Bob Oliver reported mixed activity in company stock. On February 13, 2026, he sold 9,088 shares of common stock in an open-market transaction at $43.61 per share and separately sold 21,162 shares at a weighted average price of $43.90 per share, with individual trades between $43.90 and $43.96 as noted in a footnote.
On the same date, he exercised an option for 9,088 shares of common stock, recorded as both a derivative exercise and an acquisition of common shares at an exercise price of $19.28 per share. A footnote states this option originally covered 36,353 shares and became fully exercisable on May 31, 2023. Another footnote notes 18,900 restricted stock units that will convert into common shares upon vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 30,250 shares ($1,325,339)
Net Sell
4 txns
Insider
Oliver Bob
Role
Director
Sold
30,250 shs ($1.33M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (right to buy) | 9,088 | $0.00 | -- |
| Exercise | Common Stock | 9,088 | $19.28 | $175K |
| Sale | Common Stock | 9,088 | $43.61 | $396K |
| Sale | Common Stock | 21,162 | $43.90 | $929K |
Holdings After Transaction:
Option (right to buy) — 12,118 shares (Direct);
Common Stock — 51,370 shares (Direct)
Footnotes (1)
- Includes 18,900 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $43.90 to $43.96. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. The option, representing the right to purchase a total of 36,353 shares of Common Stock, became fully exercisable on May 31, 2023.
FAQ
What did Exelixis (EXEL) director Bob Oliver do in this Form 4?
Bob Oliver reported both sales and an option exercise in Exelixis common stock. He sold shares in two open-market transactions and exercised a stock option that delivered additional common shares on the same date.
What option did Bob Oliver exercise in Exelixis (EXEL) stock?
He exercised an option covering 9,088 shares of Exelixis common stock at an exercise price of $19.28 per share. A footnote explains this option originally represented the right to purchase 36,353 shares and became fully exercisable on May 31, 2023.
Is Bob Oliver’s Exelixis (EXEL) transaction an open-market sale?
Yes. The Form 4 describes two transactions coded “S” as sales of Exelixis common stock in the open market. One block was sold at $43.61, and another at a weighted average price of $43.90 per share, within a narrow price range.
Does Bob Oliver have additional Exelixis (EXEL) equity through restricted stock units?
Yes. A footnote states 18,900 shares of Exelixis common stock will be issued to him upon vesting of restricted stock units. Each restricted stock unit represents the economic equivalent of one share of common stock when it converts.
What does the Form 4 say about the exercisability of Bob Oliver’s Exelixis option?
The filing notes that the option, covering 36,353 Exelixis common shares, became fully exercisable on May 31, 2023. The reported February 13, 2026 transaction reflects the exercise of 9,088 of those option shares into common stock.